Haemonetics Corp (HAE)

EBITDA Growth

-20.29%

Quarterly · Period ending:

HAE logo

HAE EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-20.29%
HAE Quarterly EBITDA YoY % (-80.15% → -20.29%)
High-resolution chart · PNG

HAE ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Haemonetics Corp EBITDA Growth — Quarterly
Period endingEBITDA Growth
-20.2901%
-95.6602%
0.3637%
-2.5028%
16.9533%
28.4316%
15.2842%
35.5664%
4.4784%
9.8843%
23.3657%
-6.9416%
44.2167%
19.676%
11.6018%
44.7116%
162.6976%
7.1809%
-0.0883%
1.3496%
-39.5893%
-24.3903%
-14.8506%
-31.3304%
-47.5065%
34.7782%
25.2199%
36.3718%
101.2899%
43.9726%
141.5429%
10.5435%
-31.8093%
59.9682%
-46.4383%
-2.2062%
217.1179%
-28.9688%
4.3026%
13.3128%
-43.3007%
184.1654%
128.3461%
237.8899%
37.23%
-67.3357%
2.2396%
-47.0465%
60.3966%
-13.2006%
-47.2814%
136.6428%
-10.169%
18.265%
33.7835%
-46.6713%
-45.2945%
-13.1039%
-11.3309%
-35.7689%
-35.2753%
157.7556%
-22.1974%
-21.8065%
2.0189%
-36.6553%
4.0831%
56.5759%
87.2711%
-16.6449%
79.9612%
61.5285%
22.5299%
-8.9213%
15.2426%
-32.5799%
-28.0713%
-43.8095%
-58.8316%
40.965%
18.6104%
151.3062%
90.3941%
-27.0377%
-16.3992%
4.5087%
0.0507%
22.8895%
40.2765%
74.5444%
9.8592%
0.8052%
-5.8785%
-54.9771%
201.5737%
-24.7257%
-48.6138%
-22.127%
-61.5023%
58.8252%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.